Megakaryocytes promote osteoclastogenesis in aging
dc.contributor.author | Kanagasabapathy, Deepa | |
dc.contributor.author | Blosser, Rachel J. | |
dc.contributor.author | Maupin, Kevin A. | |
dc.contributor.author | Hong, Jung Min | |
dc.contributor.author | Alvarez, Marta | |
dc.contributor.author | Ghosh, Joydeep | |
dc.contributor.author | Mohamad, Safa F. | |
dc.contributor.author | Aguilar-Perez, Alexandra | |
dc.contributor.author | Srour, Edward F. | |
dc.contributor.author | Kacena, Melissa A. | |
dc.contributor.author | Bruzzaniti, Angela | |
dc.contributor.department | Orthopaedic Surgery, School of Medicine | en_US |
dc.date.accessioned | 2021-04-02T17:05:02Z | |
dc.date.available | 2021-04-02T17:05:02Z | |
dc.date.issued | 2020-07-07 | |
dc.description.abstract | Megakaryocytes (MKs) support bone formation by stimulating osteoblasts (OBs) and inhibiting osteoclasts (OCs). Aging results in higher bone resorption, leading to bone loss. Whereas previous studies showed the effects of aging on MK-mediated bone formation, the effects of aging on MK-mediated OC formation is poorly understood. Here we examined the effect of thrombopoietin (TPO) and MK-derived conditioned media (CM) from young (3-4 months) and aged (22-25 months) mice on OC precursors. Our findings showed that aging significantly increased OC formation in vitro. Moreover, the expression of the TPO receptor, Mpl, and circulating TPO levels were elevated in the bone marrow cavity. We previously showed that MKs from young mice secrete factors that inhibit OC differentiation. However, rather than inhibiting OC development, we found that MKs from aged mice promote OC formation. Interestingly, these age-related changes in MK functionality were only observed using female MKs, potentially implicating the sex steroid, estrogen, in signaling. Further, RANKL expression was highly elevated in aged MKs suggesting MK-derived RANKL signaling may promote osteoclastogenesis in aging. Taken together, these data suggest that modulation in TPO-Mpl expression in bone marrow and age-related changes in the MK secretome promote osteoclastogenesis to impact skeletal aging. | en_US |
dc.identifier.citation | Kanagasabapathy, D., Blosser, R. J., Maupin, K. A., Hong, J. M., Alvarez, M., Ghosh, J., Mohamad, S. F., Aguilar-Perez, A., Srour, E. F., Kacena, M. A., & Bruzzaniti, A. (2020). Megakaryocytes promote osteoclastogenesis in aging. Aging, 12(14), 15121–15133. https://doi.org/10.18632/aging.103595 | en_US |
dc.identifier.issn | 1945-4589 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/25532 | |
dc.language.iso | en_US | en_US |
dc.publisher | Impact Journals | en_US |
dc.relation.isversionof | 10.18632/aging.103595 | en_US |
dc.relation.journal | Aging | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | megakaryocyte | en_US |
dc.subject | osteoclast | en_US |
dc.subject | bone marrow macrophage | en_US |
dc.subject | aging | en_US |
dc.subject | thrombopoietin | en_US |
dc.title | Megakaryocytes promote osteoclastogenesis in aging | en_US |
dc.type | Article | en_US |